FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094456 [Registered on: 09/09/2025] Trial Registered Prospectively
Last Modified On: 08/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   A Study To Observe Changes In Outer Surface of Eye And Tear Film In People With Type 2 Diabetes And Comparing It With Non-Diabetics 
Scientific Title of Study   Evaluation Of The Tear Film And Ocular Surface Alterations In Patients With Type 2 Diabetes Mellitus 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR PARUL JAIN 
Designation  PROFESSOR 
Affiliation  GURU NANAK EYE CENTRE, MAULANA AZAD MEDICAL COLLEGE 
Address  DEPARTMENT OF OPHTHALMOLOGY, MAULANA AZAD MEDICAL COLLEGE, GURU NANAK EYE CENTRE, NEW DELHI

Central
DELHI
110002
India 
Phone  9971927902  
Fax    
Email  pjain811@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR SUNIDHI RAUTHAN 
Designation  POST GRADUATE RESIDENT FIRST YEAR 
Affiliation  GURU NANAK EYE CENTRE, MAULANA AZAD MEDICAL COLLEGE 
Address  DEPARTMENT OF OPHTHALMOLOGY, MAULANA AZAD MEDICAL COLLEGE, GURU NANAK EYE CENTRE, NEW DELHI

Central
DELHI
110002
India 
Phone  9013221582  
Fax    
Email  raygre612@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR SUNIDHI RAUTHAN 
Designation  POST GRADUATE RESIDENT FIRST YEAR 
Affiliation  GURU NANAK EYE CENTRE, MAULANA AZAD MEDICAL COLLEGE 
Address  DEPARTMENT OF OPHTHALMOLOGY, MAULANA AZAD MEDICAL COLLEGE, GURU NANAK EYE CENTRE, NEW DELHI

Central
DELHI
110002
India 
Phone  9013221582  
Fax    
Email  raygre612@gmail.com  
 
Source of Monetary or Material Support  
DEPARTMENT OF OPHTHALMOLOGY, GURU NANAK EYE CENTRE, MAULANA AZAD MEDICAL COLLEGE, NEW DELHI 
 
Primary Sponsor  
Name  MAULANA AZAD MEDICAL COLLEGE 
Address  DELHI GATE, NEW DELHI,110002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR SUNIDHI RAUTHAN  GURU NANAK EYE CENTRE  O.P.D., DEPARTMENT OF OPHTHALMOLOGY, GURU NANAK EYE CENTRE, MAULANA AZAD MEDICAL COLLEGE, NEW DELHI
Central
DELHI 
9013221582

raygre612@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
MAULANA AZAD MEDICAL COLLEGE, INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  NIL 
Patients  (1) ICD-10 Condition: E11||Type 2 diabetes mellitus,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1.Group 1: Patients diagnosed with Diabetes Mellitus (Type II)
Group 2: Age and gender matched non-diabetics coming for routine checkup
2.18-50 years of age
 
 
ExclusionCriteria 
Details  1.Patients with pre-existing autoimmune disorder.
2.Patients with renal failure.
3.Patients with ocular allergy.
4.Patients on any topical medication that may affect tear film.
5.Any ocular/ophthalmic surgery or trauma, which could affect corneal sensitivity and/or tear distribution within 6 months prior to screening.
6. Current or previous use of contact lens anticipated during the study or use 3 months prior to screening.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Mean change in Impression Cytology score of both the groups.  BASELINE 
 
Secondary Outcome  
Outcome  TimePoints 
Mean change in QOL(OSDI) score, TBUT, Schirmer’s & OSS.  BASELINE 
Mean change in tear film biomarker (IL 6 levels).  BASELINE 
Correlation between ocular surface changes & the tear film biomarker.  BASELINE 
Mean change in Meiboscore using non-contact infrared meibography.  BASELINE 
Correlation of all ocular surface changes with duration & severity of diabetes (HbA1c levels).  BASELINE 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   27/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a cross-sectional comparative study comparing tear film and ocular surface alterations between diabetics and non-diabetics. This study will be conducted in Guru Nanak Eye Centre. It will comprise of two groups with sample size of 20 per group. Primary outcome will be mean change in Impression Cytology score of both groups. Secondary outcome comprises of mean change in Ocular Surface Disease Index scare, TBUT, Schirmer’s score, Ocular surface Staining, tear film biomarker IL-6, Meiboscore, and correlation between ocular surface changes and the tear film biomarker. Also correlation of all ocular surface changes with duration and severity of diabetes. 
Close